Clinical trial • Phase I • Oncology

pTTL for Colorectal cancer|Advanced colorectal cancer

Phase I trial of pTTL for Colorectal cancer|Advanced colorectal cancer. 16 participants.

Overview

Trial Therapeutic Area
Oncology
Trial Disease
Colorectal cancer|Advanced colorectal cancer
Trial Stage
Phase I
Drug Modality
Cell therapy

Key dates

Initial CTIS Submission Date
22-08-2024
First CTIS Authorization Date
05-09-2024

Trial design

Phase I trial across 5 sites in Sweden.

Target Sample Size
16

Recruitment

Planned Sample Size
16
Recruitment Window Months
78

Geography

Total Number Of Sites
5
Total Number Of Participants
16

Sweden

Earliest CTIS Part Ii Submission Date
22-08-2024
Latest Decision Or Authorization Date
17-07-2025
Processing Time Days
329
Number Of Sites
5
Number Of Participants
16

Sites

Site Name
Västmanlands sjukhus Västerås
Department Name
Department of Surgery
Contact Person Name
Maziar Nikberg
Site Name
Karolinska University Hospital
Department Name
Phase 1 unit, Center for Clinical Cancer Studies, Theme Cancer
Contact Person Name
Maximilian Kordes
Site Name
Danderyds Sjukhus AB
Department Name
Department of Surgery and Urology
Contact Person Name
Abbas Chabok
Site Name
Karolinska University Hospital
Department Name
Medical Unit Cell therapy and Allogeneic stem cell transplantation (ME CAST)
Contact Person Name
Mattias Carlsten
Site Name
Karolinska University Hospital
Department Name
Medical Unit Pelvic cancer - Colorectal cancer, Theme Cancer
Contact Person Name
Per Nilsson

Sponsor

Primary sponsor

Full Name
NEOGAP Therapeutics AB
Organisation Type
Pharmaceutical company
Country Of Registered Address
Sweden

Investigational products

Investigational Product Name
pTTL
Modality
Cell therapy
First In Human
Yes

Related trials

Other published trials that may interest you.